TL-001Retatrutide10mg
TL-001Weight Management
Retatrutide
Experimental triple-receptor agonist acting on GLP-1, GIP and glucagon pathways in metabolic research.
Vial strength
How it works
Engages three incretin and glucagon receptors at once, which researchers study for combined effects on appetite signalling and energy expenditure.
Research areas
- Appetite regulation
- Energy expenditure
- Metabolic syndrome models
Format
Lyophilised powder, single vial · 10mg
Storage
Store sealed vials at 2–8 °C away from light. Once reconstituted, keep refrigerated and use within the window stated on the batch certificate.
Reconstitution
- Let the sealed vial reach room temperature before opening.
- Wipe the stopper with an alcohol swab and use sterile technique throughout.
- Add the diluent volume listed on the batch certificate slowly down the inside wall of the vial.
- Swirl gently until clear — do not shake. Label with date and concentration.
For laboratory research only. This sheet is a general handling reference, not medical advice. It is not intended for human or veterinary use.